QGEN peer analysis
QIAGEN (QGEN) against its competitors: price, today's move, 1-year return and market value side by side.
QGEN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| A Agilent | $172.69 | -1.25% | 20.46% | – |
| BIO Bio-Rad | $372.70 | 0.14% | 22.35% | $9.95B |
| BRKR Bruker | $56.15 | -1.61% | 54.26% | $8.70B |
| DHR Danaher | $229.56 | -1.15% | 6.75% | $163.25B |
| MRVI Maravai LifeSciences | $7.45 | -4.61% | 137.26% | – |
| RGEN Repligen | $173.13 | -2.15% | 19.76% | $11.23B |
| RVTY Revvity | $152.87 | -2.63% | 67.95% | – |
| TECH Bio-Techne | $72.67 | 0.01% | 19.21% | $11.41B |
| TMO Thermo Fisher | $684.61 | -1.78% | 23.08% | $257.71B |
| TXG 10x Genomics | $64.00 | -8.71% | 414.47% | $9.13B |
| QGEN QIAGEN | $50.38 | 0.32% | 8.74% | $10.37B |
- QGEN's peers: A (Agilent), BIO (Bio-Rad), BRKR (Bruker), DHR (Danaher), MRVI (Maravai LifeSciences), RGEN (Repligen), RVTY (Revvity), TECH (Bio-Techne).
Updated 2026-11-02 17:55 UTC